July 10th 2025
Gilead Sciences has partnered with the Global Fund to supply up to 2 million doses of its long-acting HIV prevention drug, lenacapavir, to low and lower-middle income countries.
Living Longer with HIV Brings New Challenges
October 31st 2016At the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, Judith Currier, MD, from the University of California, Los Angeles, discussed the many challenges that HIV-positive individuals face as they live longer lives.
Read More
ASPIRE HIV Prevention Study Reveals Several Key Findings
October 26th 2016During the 2016 HIV Research and Prevention (HIVR4P) meeting in Chicago, researchers conducting trials to assess the safety and efficacy of the dapivirine vaginal ring announced several key findings and insights of the ASPIRE study, known as MTN-020.
Read More
HPV Vaccine May Need a Redesign Due to Changes in Circulating Strains
October 22nd 2016Changes in strain prevalence indicate that the existing 9-valent HPV vaccines may offer some protection against an additional high-risk strain that is not included in the vaccine (strain 31), potentially due to antigenic similarities with other strains.
Read More
Veterans Co-Infected with HCV and HIV Use Healthcare System at a Higher Rate
October 14th 2016A team of researchers at the University of California has found that veterans infected with both hepatitis C and human immunodeficiency virus sought treatment more often than those infected with just one of the viruses.
Read More
High Effectiveness and Increased Vaccination Rates Mark Success of HPV Vaccine
October 12th 2016In the 10 years since the human papilloma virus (HPV) vaccine first became available, a series of new studies have come out showing just how effective the virus really is and how HPV vaccination rates can be improved in adolescents.
Read More
A New Meaning to "Getting Tested"
October 6th 2016Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.
Read More
NIH Funds First National Research Network to Focus on HIV-Infected & At-Risk Youth
October 4th 2016The National Institutes of Health (NIH) has provided funding of $24 million this year to the Adolescent Medicine Trials Network for HIV/AIDS Interventions, the first clinical research group that will focus on youth infected by HIV.
Read More
US Hospitals Show No Reduction of Antibiotic Use in New 7-Year Study
September 30th 2016As individual nations attempt to make meaningful progress on stemming antibiotic use, a troubling new study shows that hospitals in the United States have continued to dispense antibiotics at a steady rate in recent years.
Read More
Michigan Varicella Outbreak Associated with Riding a School Bus
September 16th 2016A varicella outbreak that had occurred last year in Michigan is thought to be associated with riding on a school bus, which makes small, enclosed spaces, such as a school bus, a risk factor for both transmitting and acquiring airborne diseases.
Watch
New Test Can Assist in Fight Against HIV
September 9th 2016A new test that can effectively estimate HIV-negative patients’ adherence to prescribed drugs to prevent the transmission of human immunodeficiency virus (HIV) during sexual intercourse has been discovered by researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz.
Read More